There's no reason to insinuate that this info is a junk claim.
"Real trials" were done with SARs Co-2 and that the results were as described in the article referenced.
If your point is that this article is worthless because a "real trial" of "Benadryl + milk" hasn't been done for Covid-19, you are missing the point.
Its being pointed out that the specific mechanisms that "Benadryl + milk" exhibited in the earlier tests, demonstrating efficacy in inhibiting viral replication,
could reasonably be to have similar effects on Covid-19, based on the similarity of SARs Cov-2 to Covid-19.
When I explained to my Doctor recently why I believe I had Covid-19 in March-April of 2020 (smell and taste) with no memorable illness or discomfort of any kind, he pointed out that exposure to Sars Cov-2 may have provided antibodies that assisted in making the Covid-19 less virulent...My assumption based on his comment is that the 2 and 19 are pretty derned close.
The article isn't pretending that a specific study has been done, its analysis that makes the argument that what they learned about Sars Cov-2 may well be applicable to treating Covid-19.
There's no reason to insinuate that this info is a junk claim. "Real trials" were done with SARs Co-2 and that the results were as described in the article referenced.
If your point is that this article is worthless because a "real trial" of "Benadryl + milk" hasn't been done for Covid-19, you are missing the point.
Its being pointed out that the specific mechanisms that "Benadryl + milk" exhibited in the earlier tests, demonstrating efficacy in inhibiting viral replication, could reasonably be to have similar effects on Covid-19, based on the similarity of SARs Cov-2 to Covid-19.
When I explained to my Doctor recently why I believe I had Covid-19 in March-April of 2020 (smell and taste) with no memorable illness or discomfort of any kind, he pointed out that exposure to Sars Cov-2 may have provided antibodies that assisted in making the Covid-19 less virulent...My assumption based on his comment is that the 2 and 19 are pretty derned close.
The article isn't pretending that a specific study has been done, its analysis that makes the argument that what they learned about Sars Cov-2 may well be applicable to treating Covid-19.